What is the appropriate prescription regimen of omega‑3 fatty acids for a patient with hypertriglyceridemia who is currently on metoprolol 25 mg twice daily?

How to Prescribe Fish Oil for Hypertriglyceridemia

Prescribe FDA-approved icosapent ethyl (IPE) 4 grams daily (2 grams twice daily) for patients with triglycerides ≥150 mg/dL who are on maximally tolerated statin therapy and have established cardiovascular disease or diabetes with additional risk factors—do not use over-the-counter fish oil supplements as they lack proven cardiovascular benefit and are not FDA-approved for triglyceride reduction. 1

Key Decision Points Based on Triglyceride Level and Risk Status

For Triglycerides 150-499 mg/dL (Mild-Moderate Hypertriglyceridemia)

If patient has ASCVD or diabetes + ≥2 additional CV risk factors:

• Prescribe icosapent ethyl 4 grams daily (2 grams twice daily with meals) as adjunct to maximally tolerated statin therapy
• This is the ONLY omega-3 product with FDA approval and proven 25% reduction in cardiovascular events (MI, stroke, coronary revascularization, unstable angina) 1, 2
• The patient on metoprolol 25 mg twice daily would be a candidate if they meet the triglyceride and risk criteria above

If patient has no ASCVD and no diabetes:

• Focus on lifestyle modifications first (weight loss, limit fructose/alcohol, increase physical activity) 3
• Consider prescription omega-3 only after optimizing statin therapy and lifestyle changes through shared decision-making 1

For Triglycerides ≥500 mg/dL (Severe Hypertriglyceridemia)

Primary goal is pancreatitis prevention:

• Prescribe 4 grams daily of prescription omega-3 (either icosapent ethyl OR EPA+DHA preparations)
• All prescription omega-3 products reduce triglycerides by 25-30% at this dose 3, 2
• Critical distinction: EPA+DHA products will increase LDL-C by 5-10%, while icosapent ethyl (EPA-only) does not raise LDL-C 2, 4
• Complete alcohol abstinence is mandatory 3

Why NOT Over-the-Counter Fish Oil

Never recommend OTC fish oil supplements for cardiovascular risk reduction or triglyceride treatment because:

• Not FDA-approved for treating elevated triglycerides
• Variable content and purity—may contain saturated fat, oxidized lipids, contaminants
• Require large pill burden (many capsules) to match prescription doses, adding unwanted calories
• No demonstrated cardiovascular outcomes benefit
• Worse tolerability (burping, fishy taste, dyspepsia) 1

Prescription Omega-3 Products: Critical Differences

Icosapent ethyl (EPA-only):

• ONLY product proven to reduce cardiovascular events (REDUCE-IT trial)
• Does NOT raise LDL-C
• FDA-approved for ASCVD risk reduction in high-risk patients with triglycerides ≥150 mg/dL 1, 2

EPA+DHA combination products:

• FDA-approved ONLY for severe hypertriglyceridemia (≥500 mg/dL)
• NOT approved for cardiovascular risk reduction
• WILL increase LDL-C by 5-10% 2, 4
• Recent STRENGTH trial stopped for futility 5

Important Safety Considerations

Atrial fibrillation risk:

• High-dose omega-3 (4 grams daily) increases AF risk by approximately 50% (HR 1.69-1.84) 1
• In REDUCE-IT: 3.1% vs 2.1% hospitalized for AF/flutter (p=0.004) 1
• Carefully weigh cardiovascular benefit against AF risk in patients with history of AF or high AF risk
• The patient on metoprolol (a beta-blocker often used for rate control) may already have AF history—verify this before prescribing

Other adverse effects:

• Eructation, dyspepsia, taste perversion (ethyl ester preparations)
• Musculoskeletal pain, peripheral edema, constipation, gout (particularly with IPE) 1

Dosing Algorithm

1. Confirm patient is on maximally tolerated statin (or has documented statin intolerance)
2. Measure fasting or non-fasting triglycerides (non-fasting ≥175 mg/dL = fasting ≥150 mg/dL) 1
3. Assess cardiovascular risk status:
   • Established ASCVD? → Prescribe icosapent ethyl 4g daily
   • Diabetes + ≥2 additional CV risk factors? → Prescribe icosapent ethyl 4g daily
   • Neither? → Optimize lifestyle and statin first
4. Screen for AF history/risk before initiating
5. Prescribe: Icosapent ethyl 2 grams orally twice daily with meals
6. Recheck lipids in 8-12 weeks to assess response

Dietary Omega-3 Recommendation

While prescription omega-3 is indicated for the clinical scenario described, all patients should consume 2 servings of oily fish weekly (salmon, herring, sardines, mackerel—providing approximately 1-2 grams EPA+DHA per 3.5 oz serving) 3, 6. This dietary approach is insufficient for pharmacological triglyceride lowering but supports overall cardiovascular health.

The metoprolol dose mentioned (25 mg twice daily) does not interact with omega-3 fatty acids and requires no adjustment 7.